Cornerstone Wealth Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217K	Buy	291 +23	+9%	+$17.6K	0.01%	416
2025 Q4	$207K	Buy	+268	New	+$182K	0.01%	371
2025 Q2	–	Sell	-8,270	Closed	-$5.24M	–	330
2025 Q1	$5.24M	Buy	8,270 +4,405	+114%	+$3.03M	0.44%	70
2024 Q4	$2.75M	Buy	3,865 +137	+4%	+$115K	0.23%	101
2024 Q3	$3.92M	Buy	3,728 +10	+0.3%	+$11.1K	0.32%	86
2024 Q2	$3.91M	Buy	3,718 +104	+3%	+$101K	0.35%	77
2024 Q1	$3.48M	Sell	3,614 -1,457	-29%	-$1.39M	0.32%	81
2023 Q4	$4.45M	Sell	5,071 -111	-2%	-$91.4K	0.64%	46
2023 Q3	$4.26M	Sell	5,182 -87	-2%	-$68.4K	0.76%	36
2023 Q2	$3.79M	Buy	5,269 +102	+2%	+$78.6K	0.69%	57
2023 Q1	$4.25M	Sell	5,167 -61	-1%	-$46K	0.76%	45
2022 Q4	$3.77M	Sell	5,228 -71	-1%	-$52.4K	0.71%	47
2022 Q3	$3.65M	Buy	+5,299	New	+$3.34M	0.81%	46
2021 Q4	–	Sell	-4,902	Closed	-$2.97M	–	164
2021 Q3	$2.97M	Buy	+4,902	New	+$3.04M	0.52%	70